Mycobacterium tuberculosis strains resistant to streptomycin (SM), isoniazid (INH), and/or rifampin (RIF) as
Advances in health care policies in developed nations offered a goal to eradicate tuberculosis (TB) by the end of the XX century, but it reemerged due primarily to the global human immunodeficiency virus (HIV) epidemic, the large numbers of people trapped in poverty, and due to the disruption of the TB control program. However, 95% of TB cases occur in developing countries (PablosMéndez et al. 1998 ) and the disease has remained endemic for many decades.
The treatment of TB requires a multidrug regimen administrated over a long period of time, and a high level of compliance with therapy. The lack of compliance has led to an increase in drug-resistant strains of Mycobacterium tuberculosis (Cohn et al. 1997) . For these reasons, rapid identification of mycobacterial isolates, along with rapid susceptibility testing of all isolates of M. tuberculoFinancial support: subcontract from the J Hopkins University with funds provided by grant 1U19AI45432-01 from NIH (its contents are solely the responsibility of authors and do not necessarily represent the official views of NIH), CNPq (Pronex, Milênio), Faperj, Brazilsis, has become a critical step for correct therapy selection and for the prevention of the spread of resistant organisms.
In this preliminary study M. tuberculosis strains that were resistant to isoniazid (INH), rifampin (RIF) and/or streptomycin (SM) as determined by the Löwenstein-Jensen proportion method (LJPM) (Canetti et al. 1963) , and compared the results an epsilometer test (E test system; AB Biodisk, Solna, Sweden). Strains were further evaluated by a radiometric proportional drug susceptibility assay (BACTEC, Becton-Dickinson, Sparks, MD) and by DNA sequence analysis for mutations in gene regions most often associated with resistance to these drugs in order to evaluate discrepant results as well as correlations with minimum inhibitory concentration (MIC) determined by the E test. The E test was performed as previously described (Wangler & Mills 1996) with minor modification. Briefly, growth from LJ slants incubated for three weeks at 37 o C was suspended into a tube containing 3 mm glass beads and vortexed for 1 min. Following addiction of 5% PBS-Tween 80, the large particles were left to settle down and the supernatant achieved a turbidity equivalent to that of a McFarland 4 standard. This inoculum was swabbed onto Middlebrook 7H11 agar (Difco, Detroit, MI) plates (150 mm) supplemented with 0.2% tyloxapol (Sigma, US) and 10% OADC (BBL, Cockeysville, MD). After 24 h incubation at 37 o C in an atmosphere of 5% CO 2 , three E test strips (kindly provided by AB Biodisk) impregnated with gradients of INH, RIF or SM (0.016 to 256 µg/ml) were placed on the agar surface plate and incubated as described above. Susceptibility results were interpreted using the following breakpoints: INH, 0.2 µg/ml; RIF, > 1 mg/ml; SM, 5 µg/ml (NCCLS 1994) . Critical drug concentrations for BACTEC broth testing were 0.1 µg/ml for INH and 2 µg/ml for RIF and SM.
Genotypic analyses were done from crude lysates containing genomic DNA for use as templates for polymerase chain reaction (PCR). Templates for genotypic analyses were crude lysates prepared from Middlebrook 7H9 broth cultures by disruption of cells with siliconized glass beads as previously described (Plikaytis et al. 1990 ). Regions of rpoB, katG, rpsL, and inhA in which mutations most frequently associated with antituberculosis drug resistance have been found (Ramswamy & Musser 1998) , were amplified by PCR using conditions and oligonucleotide primers that were previously described (Table I) . Amplimers were evaluated for mutations using automated DNA sequence analysis performed on an ABI373 sequencing apparatus according to the protocol supplied by the manufacturer using the Big Dye TM Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems, Foster City, CA).
It test was performed blindly by different institutions involved in this study. Data analysis was performed using the software EPInfo5.
Patterns of susceptibility to INH, RIF, and SM for 25 M. tuberculosis isolates were determined by the LJPM, at Hélio Fraga National Reference Center of Ministry of Health and Noel Nutels Institute, Rio de Janeiro State Reference Laboratory for TB, Brazil. Single-drug resistance was found among 14 isolates (8 to INH, 2 to RIF, and 4 to SM) and 11 were resistant to at least two drugs: 3 were resistant to INH and SM, 7 to INH and RIF and 1 to all three drugs.
The E test failed to detect SM resistance in 6 of the 8 isolates (75%); SM resistance was confirmed by BACTEC in 5 of the 6 discrepant isolates (Table II) . None showed mutations on rpsL gene regions.
The E test results were discordant for 2 of 19 INHresistant isolates (strains 12 and 23; Table II ). The INH MIC determined by the E test for the two discordant isolates was 0.016 µg/ml and only one (strain 12) was shown to have a katG mutation. However under E test re-testing the MICs changed to 4 and 1 µg/ml, respectively, and BACTEC confirmed resistant profile. Among the remaining 17 concordant INH R strains, E test MICs were high for ) . MICs for these two, respectively, were 32 µg/ ml and 256 µg/ml). In five isolates found INH R by LJPM/ BACTEC no mutation in the katG gene region examined was detected (26%), and three of them yielded low levels of resistance (strains 7, 13, 23) and two had high MICs (strains 19, 21, Table II ). All INH-resistant isolates were examined for mutations in a 248-bp region of the inhA structural gene and one (strain 21) had a mabA-15 mutation. Most isolates that were WT in katG and inhA showed resistance at low INH MICs (≤ 1.5 µg/ml) and resistance were confirmed by BACTEC testing. Concordance between the E test and LJPM results was found initially for nine RIF-resistant isolates, seven of which were highly resistant (MIC = 256 µg/ml). Mutations in rpoB were found in five isolates: His 526 Asp, His 526 Val, His 526 Tyr, Asp 516 Val, and Ser 531 Leu. Four RIF R isolates had no rpoB mutations: two each had high (256 µg/ml, strains 6, 13) and low (4 and 2 µg/ml, strains 24, 25) RIF MICs. These latter isolates (Table II) , were retested and found susceptible by all tests. High RIF MICs found for the isolates 6 and 13 had resistant profile confirmed by all phenotypic methods. One discrepant isolate (11) was initially found to be RIF-resistant by LJPM and E test (MIC = 256 µg/ml), however by BACTEC it was susceptible. Although RIF S was confirmed by BACTEC, an rpoB mutation (His 526 Asp) was also found. Under retest LJPM give susceptible profile. One possible explanation for the discrepancies seen among strains 11, 24, and 25 may be related with hetero-resistant clones, e. g., those present in a single colony, however we could not prove this hypothesis, isolating both type of colonies, because of the samples' death.
It is well known that spontaneous resistance to isoniazid occurs once every 10 6 microorganisms and for RIF larger organism population is need (once every 10 8 ). In general, multidrug resistance is acquired in two steps, with initial INH resistance development rather than RIF resistance. In our finding 100% of RIF resistant strains were also INH resistant, this may confirm that RIF is a good marker to identify MDR M. tuberculosis (Hazbón et al. 2000) .
Our data demonstrated good overall agreement between LJPM and E test methods for INH and RIF as reported previously (Wangler & Mills 1996 , Hazbón et al. 2000 , but more discrepancies were found for SM. The extent of concordance was improved for some isolates only after re-testing. This may be related to the inoculum preparation what led a poor growth in the initial testing. Except for two M. tuberculosis isolates, SM MICs determined by the E test were low (< 4 µg/ml). However, if the endpoint interpretation for SM were lowered to 4 µg/ml as used for LJPM interpretation rather than 5 µg/ml our results would have been more concordant. No rpsL mutations were found (Table II) but this finding may not be surprising since mutations in this gene are typically associated with much higher MICs, (e.g. ≥ 500 µg/ml) and MICs among our isolates were ≤ 256 µg/ml (Cooksey et al. 1996 , Meier et al. 1996 ). An additional cause for discordance, particularly when re-testing was performed, may be due to selection of drug-resistant mutants from subcultures.
Our findings suggest that the E test may be useful for rapid screening in some sets of strains, as isolates from patients under epidemiologic investigation or those with suspicion of infection with INH-and/or RIF-resistant strains (Dobner et al. 1997 , Hazbón et al. 2000 . Nucleic acid-based assays for the detection of resistance are typically easy and rapid and may offer advantages over phenotypic tests for quick identification of MDR isolates, perhaps even for culture-negative specimens. However, as reported previously (Cooksey et al. 1997 , Ramswamy & Masser 1998 , Spindola de Miranda et al. 2001 ) and confirmed in this study, some resistant isolates may not be detected through genetic alteration of the target gene segment. In this study most of the WT profile was seen among low MIC resistant strains, however among mutated resistant strains significant correlation was detected in those with high MICs (p = 0.06).
In our preliminary study discrepancies related to molecular resistance detection were significantly higher than among phenotypic assays (14/25 x 6/25, p = 0.04). Mutations in these strains most likely were located outside of the target segment gene or other mechanisms of resistance may have been responsible (Meier et al. 1996 , Ramswamy & Masser 1998 , Spindola de Miranda et al. 2001 as already observed for INH R strains. Nonetheless good agreement was found between E test and LJPM as reported previously (Wangler & Mills 1996) , for INH and amino acid substitutions located at codon position 315 in katG was the most frequently associated genotype (Cooksey et al. 1997 , Dobner et al. 1997 . Overall, the routine use of molecular techniques for the analysis of resistance is dependent on the prevalence of the resistancecausing mutation. The use of molecular techniques seems to provide incomplete coverage and may vary between different areas (Spindola de Miranda et al. 2001 , Bártfai et al 2001 . As rapid detection methods that inherently may overcome problems related to the slow growth of M. tuberculosis, they are potentially very helpful for controlling the spread of resistant strains especially MDR strains. Until further improvements in molecular technologies for this purpose are achieved, however, confirmation of genotypic drug susceptibility results must continue to be confirmed by the most appropriate conventional phenotypic susceptibility method. Further studies must be done to enlarge the evaluated samples and looked possible mutations outside of the hot spot sequenced gene among discrepant strains.
